Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anabella Smulever

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Endocrine|May 27, 2025
A decade of active surveillance for low-risk papillary thyroid carcinoma in Argentina: persistent challenges in acceptance and discontinuation ratesAnabella Smulever, Fabián Pitoia
Endocrine|January 7, 2021
Active surveillance in small cytological indeterminate thyroid nodules: a call to common sense?Anabella Smulever, Fabián Pitoia
Archives of Endocrinology and Metabolism|September 5, 2019
Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin AmericaAnabella Smulever, Fabián Pitoia
Endocrine|April 25, 2020
High rate incidence of post-surgical adverse events in patients with low-risk papillary thyroid cancer who did not accept active surveillanceAnabella Smulever, Fabián Pitoia
Thyroid Research|March 13, 2023
Conservative management of low-risk papillary thyroid carcinoma: a review of the active surveillance experienceAnabella Smulever, Fabian Pitoia
World Journal of Clinical Oncology|September 3, 2020
Active surveillance in low risk papillary thyroid carcinomaFabian Pitoia, Anabella Smulever
Reviews in Endocrine & Metabolic Disorders|October 13, 2023
Thirty years of active surveillance for low-risk thyroid cancer, lessons learned and future directionsAnabella Smulever, Fabian Pitoia
World Journal of Clinical Oncology|February 4, 2022
New approaches for patients with advanced radioiodine-refractory thyroid cancerFabián Pitoia, Fernando Jerkovich, Pierpaolo Trimboli, et al.
Endocrine|July 13, 2026
Anaplastic thyroid carcinoma in Argentina: real-world diagnostic lags and treatment barriersAnabella Smulever, Fabián Pitoia, Erika Abelleira, et al.
Endocrine|August 6, 2020
Thyroid cancer in the Era of COVID-19Anabella Smulever, Erika Abelleira, Fernanda Bueno, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Endocrine|May 27, 2025
A decade of active surveillance for low-risk papillary thyroid carcinoma in Argentina: persistent challenges in acceptance and discontinuation ratesAnabella Smulever, Fabián Pitoia
Endocrine|January 7, 2021
Active surveillance in small cytological indeterminate thyroid nodules: a call to common sense?Anabella Smulever, Fabián Pitoia
Archives of Endocrinology and Metabolism|September 5, 2019
Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin AmericaAnabella Smulever, Fabián Pitoia
Endocrine|April 25, 2020
High rate incidence of post-surgical adverse events in patients with low-risk papillary thyroid cancer who did not accept active surveillanceAnabella Smulever, Fabián Pitoia
Thyroid Research|March 13, 2023
Conservative management of low-risk papillary thyroid carcinoma: a review of the active surveillance experienceAnabella Smulever, Fabian Pitoia
World Journal of Clinical Oncology|September 3, 2020
Active surveillance in low risk papillary thyroid carcinomaFabian Pitoia, Anabella Smulever
Reviews in Endocrine & Metabolic Disorders|October 13, 2023
Thirty years of active surveillance for low-risk thyroid cancer, lessons learned and future directionsAnabella Smulever, Fabian Pitoia
World Journal of Clinical Oncology|February 4, 2022
New approaches for patients with advanced radioiodine-refractory thyroid cancerFabián Pitoia, Fernando Jerkovich, Pierpaolo Trimboli, et al.
Endocrine|July 13, 2026
Anaplastic thyroid carcinoma in Argentina: real-world diagnostic lags and treatment barriersAnabella Smulever, Fabián Pitoia, Erika Abelleira, et al.
Endocrine|August 6, 2020
Thyroid cancer in the Era of COVID-19Anabella Smulever, Erika Abelleira, Fernanda Bueno, et al.
Pageof 2